-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$10.00488.24% Upside
Milestone Pharmaceuticals Inc. Frequently Asked Questions
-
What analysts cover Milestone Pharmaceuticals Inc.?
Milestone Pharmaceuticals Inc. has been rated by research analysts at Piper Sandler in the past 90 days.